Results 81 to 90 of about 478 (150)

Archaeosomal nanocarriers improve pharmacokinetics and bioavailability of vancomycin after oral administration

European Journal of Pharmaceutical Sciences
Vancomycin, a glycopeptide antibiotic, is typically administered intravenously (IV) for severe Gram-positive bacterial infections. While the oral route offers higher patient adherence, it is limited by poor mucosal transport, restricting its use to intestinal infections.
Viktor Sedlmayr, Julian Quehenberger, David Wurm, Mikko Gynther, Rebecca Vieth, Valerie Dürr, Pascal Gesse, Oliver Spadiut, Gert Fricker, Philipp Uhl   +9 more
openaire   +2 more sources

Formulation of a New Generation of Liposomes from Bacterial and Archeal Lipids

, 2016
Purpose: To evaluate the application of bacterial liposomes and archaeosomes as a novel drug delivery system for in vitro cytoplasmic delivery of molecules into cancer cells.Methods: Bacterial membrane lipids were extracted using chloroform and methanol.
Kargar, Mohammad, Hashemitabar, Mahmood, Saremy, Sadegh, Ramezani, Zahra, Ameri, Abdulghani, Moghimipour, Eskandar, Handali, Somayeh   +6 more
core   +1 more source

Uptake of archaeobacterial liposomes and conventional liposomes by phagocytic cells

, 1996
Liposomes in the 200 nm size range were prepared from the ether lipids extracted from various Archaeobacteria (coined archaeosomes), and from conventional lipids.
Tolson, D., Patel, G., Sprott, G., Latta, R.   +3 more
core   +1 more source

Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped souble antigens in the absence of IL-12 and protect against tumor challenge.

, 2003
Archaeosome adjuvants formulated as archaeal ether glycerolipid vesicles induce strong CD4(+) as well as CD8(+) CTL responses to entrapped soluble antigens.
Sad, Subash, Patel, G., Sprott, G., Krishnan, Lakshmi   +3 more
core  

Archaeosomes as novel antigen delivery systems1 [PDF]

FEMS Microbiology Letters, 2006
G.Dennis Sprott, Douglas L Tolson, Girishchandra B Patel   +2 more
openaire   +1 more source

Nanotechnology Platform for Advancing Vaccine Development against the COVID-19 Virus. [PDF]

Diseases, 2023
Chowdhury N, Kundu A.
europepmc   +1 more source

Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious. [PDF]

Vaccines (Basel), 2023
Akache B, Read AJ, Dudani R, Harrison BA, Williams D, Deschatelets L, Jia Y, Chandan V, Stark FC, Agbayani G, Makinen SR, Hemraz UD, Lam E, Régnier S, Zou W, Kirkland PD, McCluskie MJ.   +16 more
europepmc   +1 more source

Quantitative Analysis of Core Lipid Production in <i>Methanothermobacter marburgensis</i> at Different Scales. [PDF]

Bioengineering (Basel), 2022
Baumann LMF, Taubner RS, Oláh K, Rohrweber AC, Schuster B, Birgel D, Rittmann SKR.   +6 more
europepmc   +1 more source

Archaeosome Vaccines

, 2014
G. Dennis Sprott, Lakshmi Krishnan
openaire   +1 more source

Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant. [PDF]

Sci Rep, 2021
Akache B, Renner TM, Tran A, Deschatelets L, Dudani R, Harrison BA, Duque D, Haukenfrers J, Rossotti MA, Gaudreault F, Hemraz UD, Lam E, Régnier S, Chen W, Gervais C, Stuible M, Krishnan L, Durocher Y, McCluskie MJ.   +18 more
europepmc   +1 more source